GLP-1 Rewrites CPG Strategy

GLP-1 Rewrites CPG Strategy

The best-selling weight-loss drug GLP-1 is rewriting grocery across the aisles.

CPG is feeling the heat:

• 31m US adults already take GLP-1 drugs, representing 23% of household shoppers.
• Consumers are dramatically shifting baskets to more protein and fiber, and less carbs and sugar.
• Big CPG is being forced to adapt. General Mills cut its annual forecast due in part to GLP-1 causing “a lasting influence in the food and nutrition landscape.”

And the pace is accelerating:

• “The GLP-1 surge is still in its infancy,” reports The Wall Street Journal.  
• Search for “GLP-1 foods” just hit an all-time high in Google Trends.

10x Growth in GLP-1 Support Products

The number of CPG products positioned with “GLP-1” soared 10x in just 12 months. 

• Unique GTINs with GLP-1 positioning zoomed from 38 to 388 products in our catalog over the past year.
• “GLP-1 Support” or similar phrasing appears on both new products and repositioned products, using on-pack icons and eCommerce titles & descriptions.
• Products span the aisles from fajitas to yogurt — not just supplements.
• GLP-1 users prioritize protein per bite and favor high fiber, while shunning sugar and seeking small serving sizes, healthy snacks, and new beverages.
• Claim words are all over the road — using phrases such as “GLP-1 Activator,” “Booster,” “Friendly”, “Nutrition”, “and Support” — and all terms are unregulated by the FDA.

Some Brands Promote GLP-1 Support. Retailers Not Much.

To capture demand for “GLP-1 Support” products, CPG approaches vary widely, while retailers are lagging.

Nutrition brands launch new product lines.

• Nestlé targeted the opportunity by launching Vital Pursuit, creating bowls, fajitas, and pizzas with “GLP-1 Support” badges, gaining wide retail distribution.
• Abbott introduced Protality nutrition shakes — “specially designed for GLP-1 users”, selling multi-packs at Walmart.

Food brands extend existing product lines & deepen commercial ties.

• General Mills’ Fiber One and Conagra’s Healthy Choice display GLP-1 icons and messaging on the front of packages and via syndicated data attributes.
• Danone created Oikos Fusion yogurt as a “one-of-a-kind opportunity” to serve GLP-1 users, but skips any reference to an explicit “GLP-1 Support” claim.
• PepsiCo originally saw GLP-1 as having a negligible impact on its business, but has since aggressively embraced the trend, adding high-protein and fiber variants to Doritos, SmartFood, and SunChips, while avoiding explicit GLP-1 Support positioning.
• Mars’ CEO even joined the board of a top GLP-1 drug company.

Private label brands pump up the protein & fiber, but avoid GLP-1 positioning.

• Dozens of new protein- and fiber-rich items are rolling out, such as Kroger’s “Simple Truth Protein” product line.
• But store brands haven’t used GLP-1 positioning in titles, descriptions, or on-pack.
• While 3x consumers take GLP-1 drugs versus those who follow a keto diet, retail brands haven’t updated their product positioning beyond that older weight loss approach.

Supplement brands take a novel approach of using disclaimers.

• Wary of appearing to make a medical claim — which is a regulatory hazard for supplements especially — many brands only reference “GLP-1” in the fine-print.
• Centrum gummies state “Consult with your health care practitioner on GLP-1 and Centrum use.”
• This approach gives products the needed GLP-1 association without overt marketing.

Retailers tip-toe into eCommerce tools or miss making PDP updates.

• A few retailers have posted GLP-1 Support landing pages, like ShopRite and Walmart.
• Most retailers’ eCommerce listings only include supplements, ignoring relevant foods like Progresso’s new high-protein soups or even their own private label protein and fiber offerings.
• Titles and descriptions keep legacy references to “Keto, Paleo, Mediterranean and Weight Watchers Diet Friendly”, like Kroger’s PDP for Star Kist Tuna, without referencing GLP-1.

Get the Data: 50 Brands’ Strategies

For a summary of top strategies, click to see 50 Brands’ Strategies for GLP Support, as excerpted in this table:

Foodgraph Takeaways

GLP-1 Support wins the prize for “Food As Medicine” in the mass market.

• Traditional weight-loss approaches — like precision nutrition, meal kits, and diet apps — require high engagement or expense.
• The GLP-1 approach requires less consumer commitment and often gets better results.  
• With GLP-1, dietary adjustments are necessary  — but not extreme — to handle the muscle and intestinal effects of the drug.

Millions of U.S. adults have already benefited from the combination of GLP-1 drugs and Food As Medicine. This grocery phenomenon began in 2021 when the FDA approved the current generation of drugs, and all signs point to continued acceleration.

CPG is capitalizing. But retailers haven’t yet.

• CPG is pivoting across the aisles from chicken bowls to snack chips to supplements.  
• Strategies vary from launching new brands and products to just repositioning.  
• Private Label has embraced protein and fiber, but not yet GLP-1 positioning.
• Retailers lag in eCommerce, despite their easier digital path versus new product formulation.

Further Reading

Foodgraph, Harvesting Trends x 1M UPCs
‍Our original coverage of GLP-1 support products

ADM, Insights from Anti-Obesity Medication Users
‍80% of consumers are willing to pay more for food and beverage products.

Circana, GLP-1 Users to Represent 35% of U.S. Food and Beverage Sales
‍GLP-1 users already represent 23% of household shoppers.

Hartman Group, The impact of GLP-1s in an era of disruption
‍31m US adults currently take GLP-1 drugs to lose weight and manage diabetes.

Foodgraph Next

Our next major catalog update will arrive in time for Mother’s Day, Memorial Day, and Graduations.

How can we support your 2026 goals? Let's talk!

Warm Regards,

David Goodtree

Founder and CEO, Foodgraph